Skip to content
Novosides

Novosides

Glycosides and Glycosilation of Recombiant Proteins

Menu
  • Home
  • DNA
  • Antibody
  • Elisa Kits
  • Horse
  • Distributors
  • Contact us
Menu

Mouse CEA(Carcinoembryonic Antigen) ELISA Kit

Mouse CEA(Carcinoembryonic Antigen) ELISA Kit

Human Carcinoembryonic Antigen (CEA) ELISA Kit

RD-CEA-Hu-48Tests Reddot Biotech 48 Tests
EUR 420

Human Carcinoembryonic Antigen (CEA) ELISA Kit

RD-CEA-Hu-96Tests Reddot Biotech 96 Tests
EUR 574.8

Human Carcinoembryonic Antigen (CEA) ELISA Kit

RDR-CEA-Hu-48Tests Reddot Biotech 48 Tests
EUR 438

Human Carcinoembryonic Antigen (CEA) ELISA Kit

RDR-CEA-Hu-96Tests Reddot Biotech 96 Tests
EUR 600

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

20-abx153807 Abbexa
  • EUR 6768.00
  • EUR 3610.80
  • EUR 848.40
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

abx053218-96tests Abbexa 96 tests
EUR 801.6

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

abx255256-96tests Abbexa 96 tests
EUR 801.6

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Mu-10x96wellstestplate Cloud-Clone 10x96-wells test plate
EUR 4138.42
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Mu-1x48wellstestplate Cloud-Clone 1x48-wells test plate
EUR 445.99
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Mu-1x96wellstestplate Cloud-Clone 1x96-wells test plate
EUR 585.7
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Mu-5x96wellstestplate Cloud-Clone 5x96-wells test plate
EUR 2275.63
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Carcinoembryonic Antigen (CEA) ELISA Kit

4-SEA150Mu Cloud-Clone
  • EUR 4198.80
  • EUR 2216.40
  • EUR 586.80
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse Carcinoembryonic Antigen(CEA)ELISA Kit

QY-E20269 Qayee Biotechnology 96T
EUR 433.2

Mouse Carcinoembryonic Antigen ELISA Kit (CEA)

RK02678 Abclonal 96 Tests
EUR 625.2

Carcinoembryonic Antigen (CEA) (Mouse) ELISA Kit

E4741-100 Biovision each
EUR 966

Carcinoembryonic Antigen (CEA)

MO47049 Neuromics 0.5 ml
EUR 418.8

Carcinoembryonic Antigen (CEA)

HY-P0277 MedChemExpress 5mg
EUR 1678.8

ELISA kit for Mouse CEA (Carcinoembryonic Antigen)

ELK1130 ELK Biotech 1 plate of 96 wells
EUR 446.4
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Mouse CEA (Carcinoembryonic Antigen)

E-EL-M0232 Elabscience Biotech 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Mouse CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant

Mouse Carcinoembryonic Antigen (CEA) CLIA Kit

20-abx491146 Abbexa
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Carcinoembryonic Antigen (CEA) Protein

20-abx065720 Abbexa
  • EUR 828.00
  • EUR 343.20
  • EUR 2532.00
  • EUR 978.00
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Carcinoembryonic Antigen (CEA) Protein

20-abx065722 Abbexa
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Carcinoembryonic Antigen (CEA) ELISA Kit

20-abx151022 Abbexa
  • EUR 6373.20
  • EUR 3404.40
  • EUR 801.60
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

20-abx155329 Abbexa
  • EUR 7087.20
  • EUR 3780.00
  • EUR 886.80
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Monkey Carcinoembryonic Antigen (CEA) ELISA Kit

abx359529-96tests Abbexa 96 tests
EUR 990

Rabbit Carcinoembryonic Antigen (CEA) ELISA Kit

abx362811-96tests Abbexa 96 tests
EUR 990

Sheep Carcinoembryonic Antigen (CEA) ELISA Kit

abx364185-96tests Abbexa 96 tests
EUR 1111.2

Pig Carcinoembryonic Antigen (CEA) ELISA Kit

abx361295-96tests Abbexa 96 tests
EUR 990

Human Carcinoembryonic Antigen (CEA) ELISA Kit

abx250227-96tests Abbexa 96 tests
EUR 764.4

Chicken Carcinoembryonic Antigen (CEA) ELISA Kit

abx356418-96tests Abbexa 96 tests
EUR 990

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

abx256792-96tests Abbexa 96 tests
EUR 801.6

Human carcinoembryonic antigen, CEA ELISA Kit

CSB-E04767h-24T Cusabio 1 plate of 24 wells
EUR 198
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human carcinoembryonic antigen, CEA ELISA Kit

1-CSB-E04767h Cusabio
  • EUR 667.20
  • EUR 4634.40
  • EUR 2472.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human CEA(Carcinoembryonic Antigen) ELISA Kit

EH0090 FN Test 96T
EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Human Carcinoembryonic Antigen (CEA) ELISA Kit

LF-EK60048 Abfrontier 1×96T
EUR 814.8

Carcinoembryonic Antigen (CEA) (human) ELISA Kit

K4805-100 Biovision 100 assays
EUR 970.8
Description: Sensitive, Colorimetric Assay

Human Carcinoembryonic Antigen (CEA) ELISA Kit

PRB-5059 Cell Biolabs 96 assays
EUR 686.4

Human Carcinoembryonic Antigen (CEA) ELISA Kit

PRB-5059-5 Cell Biolabs 5 x 96 assays
EUR 2739.6

Human Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Hu-10x96wellstestplate Cloud-Clone 10x96-wells test plate
EUR 3470.83
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Human Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Hu-1x48wellstestplate Cloud-Clone 1x48-wells test plate
EUR 391.01
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Human Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Hu-1x96wellstestplate Cloud-Clone 1x96-wells test plate
EUR 507.16
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Human Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Hu-5x96wellstestplate Cloud-Clone 5x96-wells test plate
EUR 1922.21
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Human Carcinoembryonic Antigen (CEA) ELISA Kit

4-SEA150Hu Cloud-Clone
  • EUR 3531.60
  • EUR 1862.40
  • EUR 507.60
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species.

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Ra-10x96wellstestplate Cloud-Clone 10x96-wells test plate
EUR 4358.33
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids.

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Ra-1x48wellstestplate Cloud-Clone 1x48-wells test plate
EUR 464.1
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids.

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Ra-1x96wellstestplate Cloud-Clone 1x96-wells test plate
EUR 611.57
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids.

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

SEA150Ra-5x96wellstestplate Cloud-Clone 5x96-wells test plate
EUR 2392.06
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids.

Rat Carcinoembryonic Antigen (CEA) ELISA Kit

4-SEA150Ra Cloud-Clone
  • EUR 4418.40
  • EUR 2332.80
  • EUR 612.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Carcinoembryonic Antigen ELISA Kit (CEA)

RK01085 Abclonal 96 Tests
EUR 625.2

Rat Carcinoembryonic Antigen(CEA)ELISA Kit

QY-E10372 Qayee Biotechnology 96T
EUR 433.2

Rat Carcinoembryonic Antigen ELISA Kit (CEA)

RK03562 Abclonal 96 Tests
EUR 625.2

Carcinoembryonic Antigen (CEA) (Human) ELISA Kit

E4740-100 Biovision each
EUR 966

Carcinoembryonic Antigen (CEA) (Rat) ELISA Kit

E4742-100 Biovision each
EUR 836.4

Human carcinoembryonic antigen (CEA) antigen

CEA15-N-100 Alpha Diagnostics 100 ug
EUR 270

Human Carcinoembryonic Antigen (CEA) ELISA

LF-EK0161 Abfrontier 1×96T
EUR 723.6

Carcinoembryonic Antigen (CEA) Antibody

20-abx171571 Abbexa
  • EUR 844.80
  • EUR 427.20
  • 1 mg
  • 200 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx171572 Abbexa
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx102321 Abbexa
  • EUR 360.00
  • EUR 159.60
  • EUR 944.40
  • EUR 493.20
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx102322 Abbexa
  • EUR 360.00
  • EUR 159.60
  • EUR 944.40
  • EUR 493.20
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx102323 Abbexa
  • EUR 393.60
  • EUR 159.60
  • EUR 1095.60
  • EUR 560.40
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx102324 Abbexa
  • EUR 393.60
  • EUR 159.60
  • EUR 1095.60
  • EUR 560.40
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

abx120020-1mg Abbexa 1 mg
EUR 944.4

Carcinoembryonic Antigen (CEA) Antibody

20-abx128498 Abbexa
  • EUR 360.00
  • EUR 159.60
  • EUR 944.40
  • EUR 493.20
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

20-abx128499 Abbexa
  • EUR 360.00
  • EUR 159.60
  • EUR 944.40
  • EUR 493.20
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Carcinoembryonic Antigen (CEA) Antibody

abx020536-1mg Abbexa 1 mg
EUR 944.4

Carcinoembryonic Antigen (CEA) Antibody

abx020540-1mg Abbexa 1 mg
EUR 944.4

Carcinoembryonic Antigen (CEA) Antibody

abx020541-1mg Abbexa 1 mg
EUR 910.8

Carcinoembryonic Antigen (CEA) Antibody

abx020542-1mg Abbexa 1 mg
EUR 828

Carcinoembryonic Antigen (CEA) Antibody

abx020543-1mg Abbexa 1 mg
EUR 886.8

Carcinoembryonic Antigen (CEA) Antibody

abx020544-1mg Abbexa 1 mg
EUR 828

Carcinoembryonic Antigen (CEA) Antibody

abx020545-1mg Abbexa 1 mg
EUR 828

Carcinoembryonic Antigen (CEA) Antibody

abx020546-1mg Abbexa 1 mg
EUR 828

Carcinoembryonic Antigen (CEA) Antibody

abx022526-01ml Abbexa 0.1 ml
EUR 1328.4

Carcinoembryonic Antigen (CEA) Antibody

20-abx270133 Abbexa
  • EUR 560.40
  • EUR 644.40
  • EUR 326.40
  • EUR 978.00
  • EUR 427.20
  • 100 tests
  • 200 tests
  • 25 tests
  • 500 tests
  • 50 tests

Carcinoembryonic Antigen (CEA) Antibody

20-abx270165 Abbexa
  • EUR 560.40
  • EUR 644.40
  • EUR 326.40
  • EUR 978.00
  • EUR 427.20
  • 100 tests
  • 200 tests
  • 25 tests
  • 500 tests
  • 50 tests

Carcinoembryonic Antigen (CEA) Antibody

20-abx270190 Abbexa
  • EUR 560.40
  • EUR 644.40
  • EUR 326.40
  • EUR 978.00
  • EUR 427.20
  • 100 tests
  • 200 tests
  • 25 tests
  • 500 tests
  • 50 tests

Carcinoembryonic Antigen (CEA) Antibody

abx231576-100ug Abbexa 100 ug
EUR 577.2

Carcinoembryonic Antigen (CEA) Antibody

20-abx175703 Abbexa
  • EUR 410.40
  • EUR 159.60
  • EUR 1144.80
  • EUR 577.20
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Active Carcinoembryonic Antigen (CEA)

4-APA150Hu04 Cloud-Clone
  • EUR 778.02
  • EUR 331.20
  • EUR 2587.58
  • EUR 942.53
  • EUR 1765.06
  • EUR 596.40
  • EUR 6288.96
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells

Eukaryotic Carcinoembryonic Antigen (CEA)

4-EPA150Hu61 Cloud-Clone
  • EUR 614.59
  • EUR 288.00
  • EUR 1974.72
  • EUR 738.24
  • EUR 1356.48
  • EUR 487.20
  • EUR 4756.80
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: 293F cell

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Hu01 Cloud-Clone
  • EUR 485.57
  • EUR 253.20
  • EUR 1490.88
  • EUR 576.96
  • EUR 1033.92
  • EUR 400.80
  • EUR 3547.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Hu02 Cloud-Clone
  • EUR 485.57
  • EUR 253.20
  • EUR 1490.88
  • EUR 576.96
  • EUR 1033.92
  • EUR 400.80
  • EUR 3547.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Hu03 Cloud-Clone
  • EUR 485.57
  • EUR 253.20
  • EUR 1490.88
  • EUR 576.96
  • EUR 1033.92
  • EUR 400.80
  • EUR 3547.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Hu04 Cloud-Clone
  • EUR 485.57
  • EUR 253.20
  • EUR 1490.88
  • EUR 576.96
  • EUR 1033.92
  • EUR 400.80
  • EUR 3547.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Mu01 Cloud-Clone
  • EUR 588.79
  • EUR 280.80
  • EUR 1877.95
  • EUR 705.98
  • EUR 1291.97
  • EUR 469.20
  • EUR 4514.88
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Mu02 Cloud-Clone
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli

Recombinant Carcinoembryonic Antigen (CEA)

4-RPA150Ra01 Cloud-Clone
  • EUR 599.54
  • EUR 283.20
  • EUR 1918.27
  • EUR 719.42
  • EUR 1318.85
  • EUR 476.40
  • EUR 4615.68
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Carcinoembryonic Antigen expressed in: E.coli

CEA Antibody / Carcinoembryonic Antigen

RQ5159 NSJ Bioreagents 100ul
EUR 419

CEA Antibody / Carcinoembryonic Antigen

V8370-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid.

CEA Antibody / Carcinoembryonic Antigen

V8370-20UG NSJ Bioreagents 20 ug
EUR 219
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid.

CEA Antibody / Carcinoembryonic Antigen

V8370SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid.

CEA Antibody / Carcinoembryonic Antigen

V8631-100UG NSJ Bioreagents 100 ug
EUR 499
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule.

CEA Antibody / Carcinoembryonic Antigen

V8631-20UG NSJ Bioreagents 20 ug
EUR 219
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule.

CEA Antibody / Carcinoembryonic Antigen

V8631SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule.

CEA Antibody / Carcinoembryonic Antigen

V8890-100UG NSJ Bioreagents 100ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V8890-20UG NSJ Bioreagents 20ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V8890SAF-100UG NSJ Bioreagents 100ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9002-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9002-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9002IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9002SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9003-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9003-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9003IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9003SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9008-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9008-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9008IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9008SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9164-100UG NSJ Bioreagents 100ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9164-20UG NSJ Bioreagents 20ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V9164SAF-100UG NSJ Bioreagents 100ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2444-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2444-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2444IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2444SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2445-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2445-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2445SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2446-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2446-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2446IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2446SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2447-100UG NSJ Bioreagents 100 ug
EUR 499
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2447-20UG NSJ Bioreagents 20 ug
EUR 219
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2447IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V2447SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3527-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3527-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3527SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3597-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3597-20UG NSJ Bioreagents 20 ug
EUR 219
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3597IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3597SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

CEA Antibody / Carcinoembryonic Antigen

V3598-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3598-20UG NSJ Bioreagents 20 ug
EUR 219
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3598IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3598SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3599-100UG NSJ Bioreagents 100 ug
EUR 499
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3599-20UG NSJ Bioreagents 20 ug
EUR 219
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3599IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3599SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3716-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3716-20UG NSJ Bioreagents 20 ug
EUR 219
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3716IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V3716SAF-100UG NSJ Bioreagents 100 ug
EUR 499
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki]

CEA Antibody / Carcinoembryonic Antigen

V7069-100UG NSJ Bioreagents 100 ug
EUR 499
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).

CEA Antibody / Carcinoembryonic Antigen

V7069-20UG NSJ Bioreagents 20 ug
EUR 219
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).

CEA Antibody / Carcinoembryonic Antigen

V7069IHC-7ML NSJ Bioreagents 7 ml
EUR 499
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
×

Mouse CEA(Carcinoembryonic Antigen) ELISA Kit

Recent Posts

  • Compare polyclonal lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • Gene-centric metagenomics of the fiber-adherent bovine rumen microbiome reveals forage specific glycoside hydrolases.
  • Stimulation of lignocellulosic biomass hydrolysis by proteins of glycoside hydrolase family 61: structure and function of a large, enigmatic family.

Categories

  • Antibody
  • cDNA
  • DNA
  • Elisa Kits
  • Hamster
  • HEPES
  • Heterologous expression and mutagenesis of recombinant Vespa affinis hyaluronidase protein (rVesA2).
  • high
  • Horse
  • Horse serum
  • host
  • HRP
  • In Planta Glycan Engineering and Functional Activities of IgE Antibodies.
  • phosphor
  • reverse
  • RIA
  • rnai
  • TEMED
  • The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins.
  • Tomato UDP-Glucose Sterol Glycosyltransferases: A Family of Developmental and Stress Regulated Genes that Encode Cytosolic and Membrane-Associated Forms of the Enzyme.
  • Two Novel Fungal Phenolic UDP Glycosyltransferases from Absidia coerulea and Rhizopus japonicus.
  • UGT85A84 Catalyzes the Glycosylation of Aromatic Monoterpenes in Osmanthus fragrans Lour. Flowers.

Recent Posts

  • Compare polyclonal lab reagents for research
  • Compare polyclonal lab reagents for research
  • Antibody
  • cDNA
  • DNA
  • Elisa Kits
  • Hamster
  • HEPES
  • Heterologous expression and mutagenesis of recombinant Vespa affinis hyaluronidase protein (rVesA2).
  • high
  • Horse
  • Horse serum
  • host
  • HRP
  • In Planta Glycan Engineering and Functional Activities of IgE Antibodies.
  • phosphor
  • reverse
  • RIA
  • rnai
  • TEMED
  • The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins.
  • Tomato UDP-Glucose Sterol Glycosyltransferases: A Family of Developmental and Stress Regulated Genes that Encode Cytosolic and Membrane-Associated Forms of the Enzyme.
  • Two Novel Fungal Phenolic UDP Glycosyltransferases from Absidia coerulea and Rhizopus japonicus.
  • UGT85A84 Catalyzes the Glycosylation of Aromatic Monoterpenes in Osmanthus fragrans Lour. Flowers.
  • Compare polyclonal lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • Gene-centric metagenomics of the fiber-adherent bovine rumen microbiome reveals forage specific glycoside hydrolases.
  • Stimulation of lignocellulosic biomass hydrolysis by proteins of glycoside hydrolase family 61: structure and function of a large, enigmatic family.
© 2023 Novosides | Powered by Superbs Personal Blog theme